Product Information
ERYTHROMYCIN DR 333 MG TABLET is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $3.2578 per EA under NDC 13668058730. Its NADAC has been published 100 times since Nov 6, 2024.
FDA first approved this application on Jul 26, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
333 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668058730
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA211975FDA Approved
7/26/2021
TE Code
AB
On Market Since
10/21/2024
Pharmacological Classes
Price Statistics
The NADAC for ERYTHROMYCIN DR 333 MG TABLET has been published 100 times since Nov 6, 2024, and over the history we have for it it has risen 22.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.2578 per EA |
|---|---|
| All-time high | $3.9058 (Dec 11, 2024) |
| All-time low | $2.6517 (Nov 6, 2024) |
| 52-week high | $3.7275 |
| 52-week low | $3.2578 |
| Median price | $3.5825 |
| Average price | $3.5637 |
| Largest weekly change | +47.3% (Nov 20, 2024) |
| Weeks tracked | 100 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ERYTHROMYCIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Torrent Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ERYTHROMYCIN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Macrolide Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ERYTHROMYCIN DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 333 MG TABLET, manufactured by Torrent Pharmaceuticals Limited, is $3.2578 per EA (NDC 13668058730), effective Sep 30, 2026.
How has the price of ERYTHROMYCIN DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has risen 22.9%. It has been tracked across 100 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 333 MG TABLET?
Since Nov 6, 2024, the NADAC for ERYTHROMYCIN DR 333 MG TABLET has ranged from a low of $2.6517 (Nov 6, 2024) to a high of $3.9058 (Dec 11, 2024), with a median of $3.5825 per EA.
Are there cheaper alternatives to ERYTHROMYCIN DR 333 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ERYTHROMYCIN DR 333 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ERYTHROMYCIN DR 333 MG TABLET?
ERYTHROMYCIN DR 333 MG TABLET (NDC 13668058730) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.